(Press-News.org) In this week's PLoS Medicine, Jonathan Kimmelman from McGill University in Montreal, Canada and Alex London from Carnegie Mellon University in Pittsburgh, USA argue that ethical reviewers and decision-makers pay insufficient attention to threats to validity in pre-clinical studies and consult too narrow a set of evidence. They propose a better way for ethical and scientific decision makers to assess early phase studies: first, to attend to reporting and methodological quality in preclinical experiments that support claims of internal, construct, and external validity; and second, to consider evidence on risks and benefits of agents targeting related biological pathways.
In a Perspective article, James Lavery of the University of Toronto (uninvolved in the proposal) provides feedback on this proposal from the point of view of Institutional Review Boards (IRBs) and how they might better consider pre-clinical data in their deliberations. He says that the Kimmelman and London proposal is valuable "because it encourages IRB members, and other reviewers, to engage with less familiar challenges and guard against complacency in reviewing risk and benefit data from pre-clinical studies. But its true potential value likely lies in the extent to which it can forge agreement throughout the research enterprise on the need for more creative approaches to presenting and contextualizing pre-clinical evidence, and on broadening the base of responsibility for these difficult judgements."
INFORMATION:
Funding: The authors were supported by Canadian Institutes of Health Research (EOG 102823) and a fellowship from the Andrew W. Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Kimmelman J, London AJ (2011) Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty. PLoS Med 8(3): e1001010.doi:10.1371/journal.pmed.1001010
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001010
CONTACT:
Shilo Raube
sraube@andrew.cmu.edu
Perspective article by James V. Lavery
Funding: No specific funding was received to write this article.
Competing Interests: The author declares he has no competing interests in relation to this article. The author reports that he has conducted an educational session about ethical challenges in international vaccine trials for Sanofi Pasteur, and an educational session and consultation about the effective use of Community Advisory Boards for Pfizer, Inc., and has been paid for these activities.
Citation: Lavery JV (2011) How Can Institutional Review Boards Best Interpret Preclinical Data? PLoS Med 8(3):e1001011. doi:10.1371/journal.pmed.1001011
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001011
CONTACT:
James V. Lavery
St. Michael's Hospital and University of Toronto
Centre for Research on Inner City Health
Toronto, Ontario M5B 1W8
CANADA
jim.lavery@utoronto.ca
press@plos.org
END
WASHINGTON, DC, March 3, 2011 — Communication technologies that help people stay connected to the workplace are often seen as solutions to balancing work and family life. However, a new study in the March issue of the Journal of Health and Social Behavior suggests there may be a "dark side" to the use of these technologies for workers' health—and these effects seem to differ for women and men.
Using data from a national survey of American workers, University of Toronto researchers asked study participants how often they were contacted outside the workplace by phone, e-mail, ...
Hidden financial conflicts-of-interest are sneaking into published drug research through the back door, warns an international team of investigators, led by researchers from the Jewish General Hospital's Lady Davis Institute for Medical Research and McGill University in Montreal.
More and more, policy decisions and what medications doctors prescribe for their patients are being driven by large "studies of studies," called meta-analyses, which statistically combine results from many individual drug trials.
Led by Dr. Brett Thombs and McGill graduate student Michelle ...
In a study that included more than 120,000 adults who were treated for trauma, 16 percent of these patients died within 3 years of their injury, compared to an expected population mortality rate of about 6 percent, according to a study in the March 9 issue of JAMA. The researchers also found that trauma patients who were discharged to a skilled nursing facility had a significantly increased risk of death compared with patients discharged home without assistance.
Trauma can lead to significant illness or death. "To date, there have been few large studies evaluating long-term ...
Information concerning funding and author conflicts of interest disclosed in the original reports of randomized controlled trials is rarely disclosed when these data are combined in meta-analyses, according to an article in the March 9 issue of JAMA.
"Conflicts of interest (COIs) related to the funding of biomedical research by pharmaceutical companies and financial relationships between researchers and pharmaceutical companies have come under increased scrutiny in recent years. COIs may influence the framing of research questions, study design, data analysis, interpretation ...
Study participants who viewed a brief hands-only cardiopulmonary resuscitation (CPR) video were more likely to attempt CPR, and perform better quality CPR in an emergency than participants who did not view the short videos, according to research reported in Circulation: Cardiovascular Quality and Outcomes.
Each year, almost 300,000 people suffer out-of-hospital cardiac arrests in the United States. Survival rates from these events tend to be extremely low. However, research has shown that bystander CPR can double — even triple — survival from out-of-hospital cardiac ...
Participants in the first hospital-initiated, low-intensity collaborative care program to treat depression in heart patients showed significant improvements in their depression, anxiety and emotional quality of life after 6 and 12 weeks, researchers report in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Depression is a common condition in cardiovascular disease (CVD) patients which can result in poor prognosis and quality of life.
Collaborative care depression management programs use a non-physician care manager to coordinate ...
The quality of chronic disease care under the GP pay for performance system is poorer for residents of care homes than those living in the community, according to a study published on bmj.com today.
The Quality and Outcomes Framework (QOF) for general practice is a voluntary system of financial incentives, which has been in place since 2004. Part of the programme includes specific targets for GPs to demonstrate high quality care for patients with chronic diseases.
The study found that, although pay for performance systems do not invariably disadvantage residents of ...
The coalition government's Health and Social Care Bill is a missed opportunity to deliver the improvements in children's health services in England that are urgently needed, warn experts in a paper published on bmj.com today.
Ingrid Wolfe and some of the country's leading experts in child health propose a fundamentally different way of delivering children's health care that is long overdue in the UK.
The authors argue that care provided by UK children's health services is inferior in many regards to that in comparable European countries. However, the government's proposals ...
UK trained doctors and medical students from minority ethnic groups tend to underperform academically compared with their white counterparts, finds a study published on bmj.com today.
This attainment gap has persisted for many years and must be tackled to ensure a fair and just method of training and assessing current and future doctors, say the authors.
A third of all UK medical students and junior doctors are from minority ethnic groups. Although universities and the NHS are legally required to monitor the admission and progress of students and staff by ethnic group, ...
Lowering cholesterol could help the body's immune system fight viral infections, researchers have found.
Scientists at the University of Edinburgh have shown a direct link between the workings of the immune system and cholesterol levels.
Researchers found that when the body succumbs to a viral infection a hormone in the immune system sends signals to blood cells, causing cholesterol levels to be lowered.
Cholesterol produced by our cells is needed for viruses and certain bacteria to grow. Limiting our body's production of cholesterol would therefore curb the opportunity ...
